Mabion

Biologics

automatic assay HTS

The Role of High-Throughput Screening (HTS) in Cell Line Development and Process Optimization

Biologics, Drug development
quality control of biologics

Quality Control of Biologics Ensuring Safety Through Aggregation Analysis

Analytics, Biologics, GMP, Proteins
Co-Development Partnership Models in Biologics Programs

Co-Development Partnership Models in Biologics Programs

Biologics, Drug development, Mabion, Partnership
innovative biologics 2026

Innovative Biologics Expected Approvals in 2026

Antibody-drug conjugates, Biologics, Bispecific antibody, Clinical trials, EMA, FDA, Monoclonal antibody, Vaccines
Declaration of the objectives and scope of the European Biotech Act

EU Biotech Act Ignites a New Wave of Biologics Partnerships

Biologics, Clinical trials, EMA, Regulatory

Why Europe is Becoming a Global Hub for Biologics Manufacturing

Biologics, Manufacturing
upstream development

Upstream Development for High Yield Biologics Production 

Biologics, Drug development, Manufacturing
biologics characterization

Biologics Characterization for Ensuring Product Quality and Consistency

Analytics, Biologics
Monoclonal Antibody Prophylaxis for Infectious Diseases

Monoclonal Antibody Prophylaxis for Infectious Diseases – Passive Immunization and Prevention

Monoclonal antibody, Vaccines